肥厚型心肌病患者18F-FAPI PET/CT心肌摄取的功能意义:经心脏磁共振特征追踪应变分析识别
本研究纳入49例肥厚型心肌病(HCM)患者及年龄性别匹配的健康对照组,评估左心室18F-FAPI摄取程度(FAPI%)与强度(TBRmax)并与心脏磁共振特征追踪应变分析对比。HCM患者心肌18F-FAPI摄取明显高于健康人(中位TBRmax 9.1 vs 1.2,p<0.001),应变参数显著受损。节段水平18F-FAPI阳性摄取节段数(653个)多于肥厚节段(190个)和CMR组织特征阳性节段(525个),且在CMR组织特征阴性节段中,18F-FAPI阳性节段应变能力低于阴性节段。结论认为18F-FAPI成像可部分反映HCM患者潜在的应变减低。
要点
- HCM患者左心室心肌18F-FAPI摄取明显高于健康对照(中位TBRmax 9.1 vs 1.2,p<0.001)。
- HCM患者径向、圆周和纵向峰值应变均较健康对照显著受损(均p<0.001)。
- 18F-FAPI阳性摄取节段数(653个)多于肥厚节段(190个)和CMR组织特征阳性节段(525个)。
核心结论
- 18F-FAPI成像可部分反映HCM患者潜在的应变减低,且较CMR组织特征技术检测出更多受累心肌,额外识别的心肌应变能力受损。
研究设计与样本
- 本研究纳入49例HCM患者,并纳入两个年龄和性别匹配的健康对照独立组,比较左心室18F-FAPI摄取与CMR特征追踪应变分析。
- 左心室18F-FAPI活性分析包括摄取范围(FAPI%)和强度(最大靶本比,TBRmax);CMR组织特征参数包括晚期钆增强、原生T1值和细胞外容积分数;应变分析包括径向、圆周和纵向峰值应变(PS)。
主要发现
- HCM患者左心室心肌可见强烈18F-FAPI摄取,健康对照未见明显摄取(中位TBRmax 9.1 vs 1.2,p<0.001)。
- 与健康对照相比,HCM患者应变参数显著受损(平均径向PS 23.5 vs 36.0,平均圆周PS -14.5 vs -20.0,平均纵向PS -9.9 vs -16.0,均p<0.001)。
- 节段水平上,18F-FAPI活性与应变参数呈中度相关。
- 18F-FAPI阳性摄取节段数(n=653)多于肥厚节段(n=190)和CMR组织特征阳性节段(n=525)(均p<0.001)。
- 在CMR组织特征阴性的节段中,18F-FAPI阳性摄取节段的应变能力低于18F-FAPI阴性摄取节段(中位径向PS 30.5 vs 36.1,p=0.026;中位圆周PS -18.4 vs -19.7,p=0.041)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: This study aimed to evaluate the functional significance of 18F-labeled fibroblast activation protein inhibitor (18F-FAPI) activity in hypertrophic cardiomyopathy (HCM) by comparison with cardiac magnetic resonance feature-tracking (CMR-FT) strain analysis. METHODS: A total of 49 HCM patients were included in this study. Two independent control groups of healthy participants with a matched age and sex to the HCM patients were also enrolled. Left ventricular (LV) 18F-FAPI activity was analyzed for extent (FAPI%) and intensity (maximum target-to-background ratio, TBRmax). The CMR tissue characterization parameters of the LV included late gadolinium enhancement, native T1 value, and extracellular volume fraction. LV strain analysis was performed in radial, circumferential, and longitudinal peak strains (PS). RESULTS: Intense LV myocardial 18F-FAPI uptake was observed in HCM patients, whereas no obvious uptake was detected in healthy participants (median TBRmax, 9.1 vs. 1.2, p < 0.001). The strain parameters of HCM patients, compared with healthy participants, were significantly impaired (mean radial PS, 23.5 vs. 36.0, mean circumferential PS, -14.5 vs. -20.0, and mean longitudinal PS, -9.9 vs. -16.0, all p < 0.001). At segmental levels, there was a moderate correlation between 18F-FAPI activity and strain parameters. The number of positive 18F-FAPI uptake segments (n = 653) was higher than that of hypertrophic segments (n = 190) and positive CMR tissue characterization segments (n = 525) (all p < 0.001). In segments with negative CMR tissue characterization findings, the strain capacity of positive 18F-FAPI uptake segments was lower than that of negative 18F-FAPI uptake segments (median radial PS, 30.5 vs. 36.1, p = 0.026 and median circumferential PS, -18.4 vs. -19.7, p = 0.041). CONCLUSION: 18F-FAPI imaging can partially reflect the potential strain reduction in HCM patients. 18F-FAPI imaging detects more involved myocardium than CMR tissue characterization techniques, and the additionally identified myocardium has impaired strain capacity.
引用
- Zhang Y, Dong Z, Wang L, et al. Functional significance of myocardial activity at 18F-FAPI PET/CT in hypertrophic cardiomyopathy identified by cardiac magnetic resonance feature-tracking strain analysis. Eur J Nucl Med Mol Imaging. 2023. PMID: 37642705. doi:10.1007/s00259-023-06411-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。